Aspirin has been effective for acute migraines both as a solitary modality and in combination with other drugs, and thus has clinical value in treatment and prophylaxis of the migraines overall.
A portable, disposable, and home self-applied transcutaneous electrical nerve stimulation (TENS) device is effective for reducing pain among patients with migraine.
Interventions that increase dietary intake of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), with or without a decrease in linoleic acid, alter bioactive mediators that are implicated in migraine and reduce headaches, but they do not improve headache-related quality of life.
The researchers’ goal was to evaluate whether the 15-day threshold of headache days per month reflects significant differences in disability across the migraine and its spectrum.
Nerivio is a wireless remote electrical neuromodulation device approved for the acute treatment of episodic or chronic migraine in patients 12 years of age and older.
